drugset / Trial / NCT04359979

Tamsulosin for Thyroid Lid Retraction

NCT04359979

Unknown 50 enrolled Sheba Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to examine the effect of using Tamsulosin for treatment of eyelid retraction as part of thyroid eye disease. The treatment will be offered to all thyroid patients suffering from eyelid retraction who are treated at the thyroid clinic in Sheba's Ophthalmology department. All patient will receive information about the drug Tamsulosin, the possible side effects, and the alternative treatment options for retraction. Patients recruited will take 0.4mg/day Tamsulosin for 3 months and will have follow-ups at 1 week, 1 month and 3 months to evaluate the retraction status.

Timeline

Start
2020-05-01
Primary completion
2023-05-01
Completion
2023-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tamsulosin Other / unclassified 0.4 mg